| Item Type | Name |
|
Concept
|
ABO Blood-Group System
|
|
Concept
|
Urologists
|
|
Concept
|
Patient Reported Outcome Measures
|
|
Concept
|
Anastomosis, Surgical
|
|
Concept
|
Androgen Antagonists
|
|
Concept
|
Androgens
|
|
Concept
|
Administration, Intravesical
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Administration, Rectal
|
|
Concept
|
Age Factors
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Antibodies
|
|
Concept
|
Antibodies, Heterophile
|
|
Concept
|
Antigens, Differentiation
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Algorithms
|
|
Concept
|
Alleles
|
|
Concept
|
Carbon Radioisotopes
|
|
Concept
|
Urinary Bladder Diseases
|
|
Concept
|
Urinary Bladder Neck Obstruction
|
|
Concept
|
Urinary Bladder Neoplasms
|
|
Concept
|
Carcinoma, Papillary
|
|
Concept
|
Carcinoma, Renal Cell
|
|
Concept
|
Body Height
|
|
Concept
|
Bone Marrow
|
|
Concept
|
Cause of Death
|
|
Concept
|
Benzamides
|
|
Concept
|
Decision Making
|
|
Concept
|
Biopsy
|
|
Concept
|
Biopsy, Needle
|
|
Concept
|
Constriction, Pathologic
|
|
Concept
|
Chromosomes, Human, Pair 3
|
|
Concept
|
Chromosomes, Human, Pair 8
|
|
Concept
|
Deoxycytidine
|
|
Concept
|
Counseling
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Clinical Competence
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Cystitis
|
|
Concept
|
Cystoscopy
|
|
Concept
|
Cysts
|
|
Concept
|
Endoscopy
|
|
Concept
|
Compliance
|
|
Concept
|
False Negative Reactions
|
|
Concept
|
False Positive Reactions
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Eosinophilia
|
|
Concept
|
Epidemiologic Methods
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Drug Implants
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Equipment Failure
|
|
Concept
|
Early Ambulation
|
|
Concept
|
Estrogens
|
|
Concept
|
Heterozygote
|
|
Concept
|
Haplotypes
|
|
Concept
|
Health Facility Size
|
|
Concept
|
Medicare
|
|
Concept
|
Emergency Service, Hospital
|
|
Concept
|
Health Services Accessibility
|
|
Concept
|
Health Surveys
|
|
Concept
|
Humans
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Genetic Vectors
|
|
Concept
|
Genital Neoplasms, Female
|
|
Concept
|
Hematocrit
|
|
Concept
|
Hydronephrosis
|
|
Concept
|
Hematuria
|
|
Concept
|
Genitalia, Female
|
|
Concept
|
Genotype
|
|
Concept
|
Glycated Hemoglobin A
|
|
Concept
|
Hemostasis, Surgical
|
|
Concept
|
Glucocorticoids
|
|
Concept
|
Kidney Neoplasms
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Lymphoma, Follicular
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Injections, Subcutaneous
|
|
Concept
|
Neutrophils
|
|
Concept
|
New York
|
|
Concept
|
Gonadotropin-Releasing Hormone
|
|
Concept
|
Insurance, Health
|
|
Concept
|
Intensive Care Units
|
|
Concept
|
Mutation
|
|
Concept
|
Internship and Residency
|
|
Concept
|
Intraoperative Period
|
|
Concept
|
Obesity
|
|
Concept
|
Pneumonia, Aspiration
|
|
Concept
|
Microscopy, Electron
|
|
Concept
|
Microtomy
|
|
Concept
|
Phenylthiohydantoin
|
|
Concept
|
Phenylurea Compounds
|
|
Concept
|
Population Surveillance
|
|
Concept
|
Monitoring, Physiologic
|
|
Concept
|
Physician-Patient Relations
|
|
Concept
|
Practice Patterns, Physicians'
|
|
Concept
|
Physicians
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Registries
|
|
Concept
|
Regression Analysis
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Penis
|
|
Concept
|
Seminal Vesicles
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Serum Albumin
|
|
Concept
|
Risk
|
|
Concept
|
Risk Factors
|
|
Concept
|
Sex Factors
|
|
Concept
|
Robotics
|
|
Concept
|
Laparoscopy
|
|
Concept
|
Thrombocytopenia
|
|
Concept
|
Pyrimidinones
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Radiation Injuries
|
|
Concept
|
Radiography
|
|
Concept
|
Testicular Neoplasms
|
|
Concept
|
Testosterone
|
|
Concept
|
Transfection
|
|
Concept
|
Translations
|
|
Concept
|
Random Allocation
|
|
Concept
|
Weight Loss
|
|
Concept
|
Receptors, GABA-A
|
|
Concept
|
Androstane-3,17-diol
|
|
Concept
|
Electrophoresis, Gel, Two-Dimensional
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Models, Statistical
|
|
Concept
|
Linkage Disequilibrium
|
|
Concept
|
Cadherins
|
|
Concept
|
Genetic Therapy
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Treatment Failure
|
|
Concept
|
Telemedicine
|
|
Concept
|
Goserelin
|
|
Concept
|
Endometrial Neoplasms
|
|
Concept
|
Vacuum
|
|
Concept
|
Vagina
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Genetic Variation
|
|
Concept
|
Practice Guidelines as Topic
|
|
Concept
|
Sequence Analysis, DNA
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Concept
|
Hospital Mortality
|
|
Concept
|
Patient Satisfaction
|
|
Concept
|
SEER Program
|
|
Concept
|
Sickness Impact Profile
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Delivery of Health Care, Integrated
|
|
Concept
|
Open Reading Frames
|
|
Concept
|
Ureteroscopy
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Bone Marrow Neoplasms
|
|
Concept
|
Community Networks
|
|
Concept
|
Lymphoma, B-Cell
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Urinalysis
|
|
Concept
|
Mice, SCID
|
|
Concept
|
Mutation, Missense
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Mitomycin
|
|
Concept
|
Venous Thrombosis
|
|
Concept
|
Radiotherapy, Conformal
|
|
Concept
|
Leuprolide
|
|
Concept
|
Germ-Line Mutation
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Sarcoma, Endometrial Stromal
|
|
Concept
|
F2-Isoprostanes
|
|
Concept
|
Adenoma, Oxyphilic
|
|
Concept
|
Databases, Genetic
|
|
Concept
|
Carcinoma, Small Cell
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Pain Measurement
|
|
Concept
|
Palpation
|
|
Concept
|
Pressure
|
|
Concept
|
Probability
|
|
Concept
|
Guideline Adherence
|
|
Concept
|
Databases as Topic
|
|
Concept
|
Glutamate Carboxypeptidase II
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Taxoids
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Prostate
|
|
Concept
|
Metabolic Syndrome
|
|
Concept
|
Pulmonary Embolism
|
|
Concept
|
Mice
|
|
Concept
|
Rats
|
|
Concept
|
Renal Insufficiency
|
|
Concept
|
Digital Rectal Examination
|
|
Concept
|
Hepatocyte Nuclear Factor 3-alpha
|
|
Concept
|
Specimen Handling
|
|
Concept
|
Sperm Motility
|
|
Concept
|
Multimodal Imaging
|
|
Concept
|
Early Detection of Cancer
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Robotic Surgical Procedures
|
|
Concept
|
Ultrasonography
|
|
Concept
|
Protective Factors
|
|
Concept
|
Ureteral Diseases
|
|
Concept
|
Ureteral Neoplasms
|
|
Concept
|
Ureteral Obstruction
|
|
Concept
|
Urethra
|
|
Concept
|
Urethral Neoplasms
|
|
Concept
|
Urethral Stricture
|
|
Concept
|
Urinary Catheterization
|
|
Concept
|
Urinary Incontinence
|
|
Concept
|
Urinary Tract Infections
|
|
Concept
|
Urination Disorders
|
|
Concept
|
Urography
|
|
Concept
|
Urologic Diseases
|
|
Concept
|
Urologic Neoplasms
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Comorbidity
|
|
Concept
|
Chemoradiotherapy
|
|
Concept
|
Gene Expression Regulation, Neoplastic
|
|
Concept
|
Selection Bias
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Incidence
|
|
Concept
|
Prevalence
|
|
Concept
|
Survival Rate
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Logistic Models
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Transcriptome
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Single-Blind Method
|
|
Concept
|
Blood Loss, Surgical
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
Genes, Tumor Suppressor
|
|
Concept
|
Ultrasound, High-Intensity Focused, Transrectal
|
|
Concept
|
Carboplatin
|
|
Concept
|
Databases, Bibliographic
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Hospital Costs
|
|
Concept
|
Nomograms
|
|
Concept
|
Body Size
|
|
Concept
|
Waist-Hip Ratio
|
|
Concept
|
Keratin-14
|
|
Concept
|
Quantitative Trait Loci
|
|
Concept
|
Early Diagnosis
|
|
Concept
|
Dietary Supplements
|
|
Concept
|
Comparative Effectiveness Research
|
|
Concept
|
Checklist
|
|
Concept
|
Propensity Score
|
|
Concept
|
Patient Preference
|
|
Concept
|
Octamer Transcription Factor-3
|
|
Concept
|
Gene Expression Profiling
|
|
Concept
|
Natural Orifice Endoscopic Surgery
|
|
Concept
|
Healthcare Disparities
|
|
Concept
|
Physicians, Primary Care
|
|
Concept
|
Anabolic Agents
|
|
Concept
|
Consensus
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Sarcopenia
|
|
Concept
|
Genetic Loci
|
|
Concept
|
Induction Chemotherapy
|
|
Concept
|
Biopsy, Large-Core Needle
|
|
Concept
|
Narrow Band Imaging
|
|
Concept
|
Value-Based Purchasing
|
|
Concept
|
Tobacco Smoking
|
|
Concept
|
Aldo-Keto Reductase Family 1 Member C3
|
|
Concept
|
Aspirin
|
|
Concept
|
Attitude to Health
|
|
Concept
|
Diagnosis, Differential
|
|
Concept
|
Diethylstilbestrol
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Dissection
|
|
Concept
|
DNA Mutational Analysis
|
|
Concept
|
Florida
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Forecasting
|
|
Concept
|
Hysterectomy
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Infertility, Male
|
|
Concept
|
Mass Screening
|
|
Concept
|
Medicaid
|
|
Concept
|
Organ Size
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Ovariectomy
|
|
Academic Article
|
Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
|
|
Academic Article
|
Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire.
|
|
Academic Article
|
Primary renal carcinoid tumor.
|
|
Academic Article
|
Adverse prognostic significance of capsular incision with radical retropubic prostatectomy.
|
|
Academic Article
|
Benefit of radical cystectomy in the elderly patient with significant co-morbidities.
|
|
Academic Article
|
Robotic assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: a prospective assessment of postoperative pain.
|
|
Academic Article
|
Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy.
|
|
Academic Article
|
Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.
|
|
Academic Article
|
Sperm banking: use and outcomes in patients treated for testicular cancer.
|
|
Academic Article
|
Assessing retroperitoneal lymphadenectomy experience in United States urological residency programs.
|
|
Academic Article
|
Erectile function outcome reporting after clinically localized prostate cancer treatment.
|
|
Academic Article
|
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial.
|
|
Academic Article
|
Urothelial carcinoma of the bladder metastatic to bone marrow presenting as isolated thrombocytopenia.
|
|
Academic Article
|
Contemporary open radical cystectomy: analysis of perioperative outcomes.
|
|
Academic Article
|
The von Hippel-Lindau gene: turning discovery into therapy.
|
|
Academic Article
|
The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.
|
|
Academic Article
|
Positive surgical margins at radical prostatectomy: much ado about nothing?
|
|
Academic Article
|
Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device.
|
|
Academic Article
|
Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.
|
|
Academic Article
|
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
|
|
Academic Article
|
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.
|
|
Academic Article
|
Reply by Authors.
|
|
Academic Article
|
Urology perspective on the expanding world of germline testing for prostate cancer.
|
|
Academic Article
|
Editorial Comment.
|
|
Academic Article
|
The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer.
|
|
Academic Article
|
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.
|
|
Academic Article
|
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
|
|
Academic Article
|
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
|
|
Academic Article
|
Can semen analysis predict the presence of antisperm antibodies in patients with primary infertility?
|
|
Academic Article
|
Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk.
|
|
Academic Article
|
Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.
|
|
Academic Article
|
Increased body mass index predicts increased blood loss during radical cystectomy.
|
|
Academic Article
|
Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series.
|
|
Academic Article
|
Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
|
|
Academic Article
|
Urethral recurrence in patients following orthotopic urinary diversion.
|
|
Academic Article
|
Mechanisms leading to the development of hormone-resistant prostate cancer.
|
|
Academic Article
|
Patterns of initial transitional cell recurrence in patients after cystectomy.
|
|
Academic Article
|
Toxicity following high-dose salvage radiotherapy after radical prostatectomy.
|
|
Academic Article
|
The association between body size, prostate volume and prostate-specific antigen.
|
|
Academic Article
|
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
|
|
Academic Article
|
Association of procedure volume with radical cystectomy outcomes in a nationwide database.
|
|
Academic Article
|
Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients.
|
|
Academic Article
|
Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.
|
|
Academic Article
|
Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?
|
|
Academic Article
|
Castration-resistant prostate cancer: AUA Guideline.
|
|
Academic Article
|
An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.
|
|
Academic Article
|
Korean version of the functional assessment of cancer therapy (FACT)-vanderbilt cystectomy index (VCI): translation and linguistic.
|
|
Academic Article
|
Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma.
|
|
Academic Article
|
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
|
|
Academic Article
|
The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
|
|
Academic Article
|
Advances in the management of castration resistant prostate cancer.
|
|
Academic Article
|
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
|
|
Academic Article
|
Recent trends in the management of advanced prostate cancer.
|
|
Academic Article
|
Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial.
|
|
Academic Article
|
Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer.
|
|
Academic Article
|
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
|
|
Academic Article
|
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines.
|
|
Academic Article
|
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
|
|
Academic Article
|
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
|
|
Academic Article
|
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
|
|
Academic Article
|
A history of the Society of Urologic Oncology.
|
|
Academic Article
|
Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index.
|
|
Academic Article
|
Radical cystectomy for bladder cancer: the case for early intervention.
|
|
Academic Article
|
Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
|
|
Academic Article
|
Assessing urinary diversion experience in urologic residency programs-are we adequately training the next generation?
|
|
Academic Article
|
Urothelial carcinoma of the prostate.
|
|
Academic Article
|
Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy.
|
|
Academic Article
|
The evidence-based pathway for peri-operative management of open and robotically assisted laparoscopic radical prostatectomy.
|
|
Academic Article
|
Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia.
|
|
Academic Article
|
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
|
|
Academic Article
|
Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men.
|
|
Academic Article
|
Neovesical-urethral anastomotic stricture after orthotopic urinary diversion: presentation and management.
|
|
Academic Article
|
Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes.
|
|
Academic Article
|
Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series.
|
|
Academic Article
|
Transition from androgenic to neurosteroidal action of 5a-androstane-3a, 17ß-diol through the type A ?-aminobutyric acid receptor in prostate cancer progression.
|
|
Academic Article
|
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018.
|
|
Academic Article
|
8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer.
|
|
Academic Article
|
A prospective evaluation of leak point pressure, bladder compliance and clinical status in myelodysplasia patients with tethered spinal cords.
|
|
Academic Article
|
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
|
|
Academic Article
|
Clinical significance of repeat sextant biopsies in prostate cancer patients.
|
|
Academic Article
|
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.
|
|
Academic Article
|
Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction.
|
|
Academic Article
|
[Incidence and clinical significance of false-negative sextant biopsies of the prostate].
|
|
Academic Article
|
Causes of increased length of stay following radical cystectomy.
|
|
Academic Article
|
Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage.
|
|
Academic Article
|
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
|
|
Academic Article
|
A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
|
|
Academic Article
|
Guideline for the management of clinically localized prostate cancer: 2007 update.
|
|
Academic Article
|
Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer.
|
|
Academic Article
|
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy.
|
|
Academic Article
|
Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer.
|
|
Academic Article
|
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
|
|
Academic Article
|
Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist.
|
|
Academic Article
|
Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns.
|
|
Academic Article
|
Salvage Surgery After Renal Mass Ablation.
|
|
Academic Article
|
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.
|
|
Academic Article
|
Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review.
|
|
Academic Article
|
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup.
|
|
Academic Article
|
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
|
|
Academic Article
|
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
|
|
Academic Article
|
The Growth of Integrated Care Models in Urology.
|
|
Academic Article
|
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.
|
|
Academic Article
|
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
|
|
Academic Article
|
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.
|
|
Academic Article
|
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease.
|
|
Academic Article
|
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
|
|
Academic Article
|
Correction to: Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease.
|
|
Academic Article
|
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54].
|
|
Academic Article
|
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group.
|
|
Academic Article
|
Kidney Cancer Incidence and Mortality Disparities Involving American Indians/Alaska Natives: An Analysis of the Oklahoma Central Cancer Registry (OCCR).
|
|
Academic Article
|
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer.
|
|
Academic Article
|
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
|
|
Academic Article
|
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
|
|
Academic Article
|
Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023).
|
|
Academic Article
|
Editorial Commentary.
|
|
Academic Article
|
Editorial Commentary.
|
|
Academic Article
|
Editorial Commentary.
|
|
Academic Article
|
Proper Sequencing of Treatment for Castrate Resistant Prostate Cancer.
|
|
Academic Article
|
The Influence of Access Related Factors on Adherence to Clinical Practice Guidelines for Muscle Invasive Bladder Cancer.
|
|
Academic Article
|
Implementation of the AUA Castration Resistant Prostate Cancer Guidelines into Practice: Establishing a Multidisciplinary Clinic.
|
|
Academic Article
|
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
|
|
Academic Article
|
Editorial Commentary.
|
|
Academic Article
|
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.
|
|
Academic Article
|
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
|
|
Academic Article
|
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy.
|
|
Academic Article
|
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
|
|
Academic Article
|
Advances in diagnosis and treatment of bladder cancer.
|